BeStock  
Stocks › Biotechnology › CRMD

CorMedix CRMD

US equityMarket cap rank #3659Biotechnology
$5.27 +$0.19 (+3.74%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $5.32 +0.95%
Open$4.96
Prev close$5.08
Day range$4.95 – $5.32
Volume3.61M
Market cap$419.16M
P/E (TTM)8.2
Dividend yield–

Analyst view

ConsensusBuy
Analysts5
Average target$14.00+165.7% vs. price
  • Buy 100%
Low $13.00Now $5.27Avg $14.00High $16.00

Recent rating changes

The last 20 actions on file set price targets from $13.00 to $16.00, averaging $13.84.

DateFirmRatingTarget
13 Nov 2026 H.C. Wainwright BUY $13.00
13 Nov 2026 Oppenheimer BUY $13.00
12 Nov 2026 RBC Capital BUY $14.00
10 Nov 2026 Needham BUY $14.00
10 Nov 2026 H.C. Wainwright BUY $13.00
10 Nov 2026 RBC Capital BUY $15.00
9 Nov 2026 H.C. Wainwright BUY $13.00
2 Nov 2026 H.C. Wainwright BUY $13.00
20 Oct 2026 Leerink Partners BUY $16.00
8 Oct 2026 RBC Capital BUY $14.00
14 Aug 2026 H.C. Wainwright BUY $13.00
13 Aug 2026 Needham BUY $15.00
13 Aug 2026 RBC Capital BUY $14.00
7 Jul 2026 RBC Capital BUY $13.00
15 May 2026 Truist Financial BUY –
15 May 2026 Leerink Partners BUY $15.00
15 May 2026 H.C. Wainwright BUY $13.00
14 May 2026 Needham BUY $15.00
14 May 2026 H.C. Wainwright BUY $13.00
14 May 2026 RBC Capital BUY $14.00

Discussion

No comments yet — be the first to weigh in on CRMD.

Sign in to join the discussion.

Scroll to Top